Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/poseida-therapeutics-provides-updates-and-financial-results-for-the-third-quarter-of-2024-302299335.html
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-new-preclinical-data-supporting-non-viral-gene-editing-with-p-klkb1-101-for-the-treatment-of-hereditary-angioedema-302285382.html
27 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/poseida-therapeutics-reports-positive-interim-phase-1-results-for-allogeneic-car-t-therapy-p-bcma-allo1-with-high-overall-response-rates-in-heavily-pretreated-relapsedrefractory-multiple-myeloma-patients-302261471.html
05 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-new-clinical-data-from-phase-1-study-of-allogeneic-car-t-p-bcma-allo1-in-patients-with-relapsedrefractory-multiple-myeloma-at-21st-international-myeloma-society-annual-meeting-302239426.html
14 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/poseida-therapeutics-provides-updates-and-financial-results-for-the-first-quarter-of-2024-302145383.html
02 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/astellas-and-poseida-therapeutics-enter-into-research-collaboration-and-license-agreement-to-develop-novel-allogeneic-cell-therapies-in-oncology-302133127.html
ABOUT THIS PAGE
Poseida Therapeutics, Inc is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Rimiducid bulk with DMF offered by Poseida Therapeutics, Inc
LOOKING FOR A SUPPLIER?